Search Results - "Sørensen, Michala S."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Preoperative BMD does not influence femoral stem subsidence of uncemented THA when the femoral T-score is > -2.5 by Dyreborg, Karen, Sørensen, Michala S, Flivik, Gunnar, Solgaard, Søren, Petersen, Michael M

    Published in Acta orthopaedica (01-10-2021)
    “…Background and purpose - It is believed that in uncemented primary total hip arthroplasty (THA) the anchorage of the stem is dependent on the level of bone…”
    Get full text
    Journal Article
  2. 2

    Long‐term results of the Global Modular Replacement System tumor prosthesis for reconstruction after limb‐sparing bone resections in orthopedic oncologic conditions: Results from a national cohort by Yilmaz, Müjgan, Sørensen, Michala S., Sæbye, Casper, Baad‐Hansen, Thomas, Petersen, Michael M.

    Published in Journal of surgical oncology (01-08-2019)
    “…Background and Objectives We investigated implant revision, implant failure, and amputation risk after limb‐sparing bone tumor surgery using the Global Modular…”
    Get full text
    Journal Article
  3. 3

    Life Expectancy After Treatment of Metastatic Bone Disease: An International Trend Analysis by Rogers, Davis L, Raad, Micheal, Rivera, Julio A, Wedin, Rikard, Laitinen, Minna, Sørensen, Michala S, Petersen, Michael M, Hilton, Thomas, Morris, Carol D, Levin, Adam S, Forsberg, Jonathan A

    “…The decision to treat metastatic bone disease (MBD) surgically depends in part on patient life expectancy. We are unaware of an international analysis of how…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Major surgery for metastatic bone disease is not a risk for 30-day mortality: a population-based study from Denmark by Ladegaard, Thea H, Sørensen, Michala S, Petersen, Michael M

    Published in Acta orthopaedica (18-08-2023)
    “…Background and purpose: Surgery for bone metastases in the appendicular skeleton (aBM) is a trade-off between limb function and survival. A previous study from…”
    Get full text
    Journal Article
  6. 6

    Patient and implant survival following joint replacement because of metastatic bone disease: A cross-sectional study of 130 patients with 140 joint replacements by Sørensen, Michala S, Gregersen, Kristine G, Grum-Schwensen, Tomas, Hovgaard, Dorrit, Petersen, Michael M

    Published in Acta orthopaedica (01-06-2013)
    “…Background Patients suffering from a pathological fracture or painful bony lesion because of metastatic bone disease often benefit from a total joint…”
    Get full text
    Journal Article
  7. 7

    Plasma YKL-40 as a biomarker in patients with nonmetastatic bone and soft tissue sarcomas: a prospective exploratory clinical study by Thorn, Andrea P., Harving, Mette L., Lausten, Gunnar S., Johansen, Julia S., Sørensen, Michala S., Petersen, Michael M.

    Published in IJS oncology (01-06-2020)
    “…YKL-40 is a glycoprotein with a role in inflammation, tissue remodeling, tumor angiogenesis, and protection against apoptosis. We hypothesized that high…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Patient and implant survival following joint replacement because of metastatic bone disease by Sørensen, Michala S, Gregersen, Kristine G, Grum-Schwensen, Tomas, Hovgaard, Dorrit, Petersen, Michael M

    Published in Acta orthopaedica (01-06-2013)
    “…Background Patients suffering from a pathological fracture or painful bony lesion because of metastatic bone disease often benefit from a total joint…”
    Get full text
    Journal Article